Inappropriate use of steroid and pneumocystis jiroveci pneumonia: report of two cases.
Tabarsi
P
P
National Research Institute of TB and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran. tabarsi@nritld.ac.ir
Mirsaeidi
M
M
Amiri
M
M
Karimi
S
S
Masjedi
M R
MR
Mansouri
D
D
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001706:Biopsy; D016535:Bronchial Hyperreactivity / Q000188:drug therapy; D001999:Bronchoscopy; D003422:Critical Care; D004300:Doping in Sports; D017809:Fatal Outcome; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008487:Medical History Taking; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D011239:Prednisolone / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011239:Prednisolone